Autoimmune Diseases: all 672 studies
Page 4 of 7. Open to participants first (272), then studies with results posted, then the rest; newest registration first within each.
- Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune DiseasesCompletedNCT03122431Phase 4Results posted
- Women Empowered to Live With Lupus StudyCompletedNCT02988661Not applicableResults posted
- Day and Night Closed-loop in Young People With Type 1 DiabetesCompletedNCT02925299Not applicableResults posted
- A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS PtsCompletedNCT02899377Not applicableResults posted
- Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar ProteinosisCompletedNCT02702180Phase 2Results posted
- Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative ColitisCompletedNCT02647866Phase 2Results posted
- A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy ParticipantsCompletedNCT02219256Phase 1Results posted
- Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune DiseasesCompletedNCT02040116Phase 4Results posted
- Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistryCompletedNCT01729455Results posted
- Belimumab Assessment of Safety in SLECompletedNCT01705977Phase 4Results posted
- Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/2Results posted
- Use of Cross-linked Donor Corneas as Carriers for the Boston KeratoprosthesisCompletedNCT01582880Phase 1/2Results posted
- IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
- A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)CompletedNCT01527383Phase 2Results posted
- A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)TerminatedNCT01489956Early Phase 1Results posted
- On Open-Label Study in Participants With Systemic Lupus ErythematosusTerminatedNCT01488708Phase 3Results posted
- Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee PainCompletedNCT01351805Not applicableResults posted
- Eltrombopag for Moderate Aplastic AnemiaCompletedNCT01328587Phase 2Results posted
- Intravenous Immunoglobulin for PANDASCompletedNCT01281969Phase 3Results posted
- Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS DeviceCompletedNCT01210716Phase 3Results posted
- A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01205438Phase 3Results posted
- A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01196091Phase 3Results posted
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
- Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD)CompletedNCT00931489Phase 2Results posted
- Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With MycophenolateCompletedNCT00351377Phase 3Results posted
- Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy ProjectCompletedNCT00116272Results posted
- Scleroderma: Cyclophosphamide or TransplantationCompletedNCT00114530Phase 2/3Results posted
- FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.WithdrawnNCT07604792Early Phase 1
- A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07583030Early Phase 1
- Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With MethotrexateCompletedNCT07472166Phase 4
- A Clinical Study of AFN50 in the Treatment of Autoimmune DiseasesWithdrawnNCT07448298Early Phase 1
- Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).CompletedNCT07264517Phase 2
- A Trial of Academic Detailing to Promote Prescribing of BiosimilarsActive, not recruitingNCT07221890Not applicable
- An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)TerminatedNCT07188844Phase 2
- Longevity Diet and the Fasting-mimicking DietCompletedNCT07065955
- A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune DiseasesTerminatedNCT07049081Phase 1
- RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple SclerosisWithdrawnNCT07006805Phase 1/2
- Occupational and Environmental Causes of Autoimmune DiseasesCompletedNCT07000903Not applicable
- Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune DiseasesWithdrawnNCT06993493Not applicable
- Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune DiseasesWithdrawnNCT06983964Not applicable
- Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease WomenCompletedNCT06976151Not applicable
- A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren'sActive, not recruitingNCT06928142Phase 2
- A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT06866080Early Phase 1
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active, not recruitingNCT06843239Phase 2
- A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.CompletedNCT06827457Phase 1
- A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇCompletedNCT06824896
- Psychosocial Stress on QOL in Saudi Arabian Patients With Alopecia AreataCompletedNCT06802705
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy ParticipantsCompletedNCT06797375Phase 1
- A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisActive, not recruitingNCT06754462Phase 2
- CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)WithdrawnNCT06752876Phase 1
- Vitamin D, Hashimato's Thyroiditis and Thyroid FunctionsCompletedNCT06726967
- PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFCompletedNCT06683612Phase 1
- IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisSuspendedNCT06677710Phase 1
- A Dose Escalating Study of HC002 in Healthy Adult VolunteersCompletedNCT06670274Phase 1
- A Study of CAR-T Cells Targeting Autoimmune DiseasesWithdrawnNCT06661811Not applicable
- Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunityActive, not recruitingNCT06620913
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseCompletedNCT06587828
- Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune DiseasesSuspendedNCT06549296Early Phase 1
- Complement C5 mAb in the Treatment of Anti-GBM DiseaseCompletedNCT06513338Phase 2
- Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human SubjectsCompletedNCT06491979Not applicable
- Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune DiseaseCompletedNCT06488209Phase 1
- Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary SupplementationCompletedNCT06470412Not applicable
- A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune DiseaseWithdrawnNCT06413511Phase 1
- Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWithdrawnNCT06411639Phase 1
- A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT06411249Phase 4
- KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisTerminatedNCT06400303Phase 1/2
- Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive TherapyCompletedNCT06394466
- Study of Single Doses of SBT777101 in Subjects With Hidradenitis SuppurativaActive, not recruitingNCT06361836Phase 1
- KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisTerminatedNCT06342960Phase 1/2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological DiseasesCompletedNCT06342713Phase 1
- A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy ParticipantsCompletedNCT06342700Phase 1
- A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeTerminatedNCT06312020Phase 2
- Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Active, not recruitingNCT06294236Phase 1
- The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
- Analysis of TPE Treatments With multiFiltratePROActive, not recruitingNCT06272084
- A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
- A SHR0302 BA Study on Healthy SubjectsCompletedNCT06202612Phase 1
- Gut Microbiota In Children With Autoimmune Liver Disease and Its Effect on Treatment ResponseCompletedNCT06183190
- Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on ChildrenCompletedNCT06035614Not applicable
- Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune DiseasesActive, not recruitingNCT06029335
- Exploring Outcomes and Characteristics of Myasthenia Gravis 2CompletedNCT06002945
- Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
- Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusActive, not recruitingNCT05966480Phase 2
- Anti-Argonaute Antibodies for the Diagnosis of Sensory NeuronopathiesCompletedNCT05966350
- KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisTerminatedNCT05938725Phase 1/2
- A Study of Safety and Drug Levels of HIB210 in Healthy VolunteersCompletedNCT05928585Phase 1
- Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active, not recruitingNCT05925803Phase 3
- The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisCompletedNCT05917184
- Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareActive, not recruitingNCT05910840Not applicable
- Compassionate Use of Dupilumab for Adult Patients With Bullous PemphigoidApproved for marketingNCT05906706
- First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641CompletedNCT05853835Phase 1
- Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study.CompletedNCT05841719Not applicable
- Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy SubjectsCompletedNCT05807971Phase 1
- A Study of Telitacicept for IgA Nephropathy (TELIGAN)Active, not recruitingNCT05799287Phase 3
- Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility StudyCompletedNCT05792176Not applicable
- MUSic Therapy In Complex Specialist NeurorehabilitationCompletedNCT05777499Not applicable
- Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBDStatus unknownNCT05771363
- Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunityStatus unknownNCT05745792
- ICT Tools for the Diagnosis of Autoimmune DiseasesCompletedNCT05715970Not applicable
- Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 DiabetesActive, not recruitingNCT05683990Phase 2